CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- 4 Planned sale Chief Scientific Officer sold 3,061 shares at $6.87 ($21,029)
- 4 Planned sale Chief Development Officer sold 3,009 shares at $6.87 ($20,672)
- 4 Planned sale Chief Strategy Officer sold 1,895 shares at $6.84 ($12,962)
- 4 Grant or award Dugel Pravin acquired 2,750,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 79,000 shares (grant or award)
- 4 Grant or award Notman Donald acquired 115,000 shares (grant or award)
- 4 Grant or award Chief Strategy Officer acquired 111,000 shares (grant or award)
- 4 Open-market sale Notman Donald sold 17,420 shares at an average $7.82 ($136,239)
- 4 Planned sale Chief Scientific Officer sold 2,948 shares at $9.01 ($26,561)
- 4 Planned sale Chief Development Officer sold 2,897 shares at $9.01 ($26,102)
- 4 Planned sale Chief Strategy Officer sold 1,814 shares at $9.00 ($16,326)
- 4 Planned sale Dugel Pravin sold 20,680 shares at $9.01 ($186,327)
- 4 Grant or award Chief Legal Officer acquired 98,700 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Development Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 100,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Notman Donald acquired 11,034 shares (grant or award)
- 4 Planned sale Chief Strategy Officer sold 1,832 shares at $9.02 ($16,525)
Page 5 of 18 · 354 filings